U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06918054) titled 'Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia' on Dec. 06, 2024.
Brief Summary: This current study will implement a proposed whole program of monitoring and prevention acute hepatic injury during the time of induction chemotherapy in children and adolescent with ALL.
Study Start Date: Nov. 17, 2023
Study Type: INTERVENTIONAL
Condition:
Leukaemia (Acute)
Acute Lymphoblastic Leukemia
Intervention:
DIETARY_SUPPLEMENT: Dietary modification
Patients will follow Mediterranean Diet (MD), this diet is characterized by a high intake of vegetables, fruit, whole cereals, legumes, nuts, and fish and a lo...